Calendar
November 11, 2009
The other influenza: Haemophilus influenzae type b (Hib) vaccine shortage and public health response — United States, 2008 – 2009
Group Health Research Institute
Please join us for a special seminar presented by Michael L. Jackson, PhD, MPH.
As an Epidemic Intelligence Service (EIS) officer at the Centers for Disease Control and Prevention, Dr. Jackson works on surveillance, research, and policy related to vaccine-preventable diseases. He is particularly focused on Haemophilus influenzae, pertussis, and meningococcal disease. Before joining the EIS program Dr. Jackson was a graduate student at the University of Washington and a post-doctoral fellow at Group Health Research Institute (formerly the Center for Health Studies). His dissertation and related research focused on methods for evaluating vaccine effectiveness and on the use of administrative data in epidemiologic studies.
Abstract:Haemophilus influenzae type b (Hib) was once the most common cause of invasive bacterial disease among young children in the United States. Since 1988, routine use of Hib protein conjugate vaccines has reduced the incidence of invasive Hib by more than 99 percent. However, in December 2007, Merck & Co., Inc. voluntary recalled certain lots of their Hib vaccines and suspended Hib vaccine production. As Merck had provided roughly 50 percent of the United States Hib vaccine supply, Merck's recall and production suspension led to a shortage of Hib vaccines in the United States. In this talk Dr. Jackson will review the public health response to the shortage, including vaccination policy, public health practice, and scientific research.
3:00 pm - 4:00 pm
Conference Room 1509A, Metropolitan Park East
For more information:
Colton Barlow
